Índice Bovespa

US Dollar vs BRL

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Omni Bridgeway Ltd (PK) (IMMFF)
Omni Bridgeway Ltd (PK) (IMMFF) Notícias

IMMFF

Omni Bridgeway (PK) (IMMFF)

Omni Bridgeway Ltd (PK)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:IMMFF

1

Data	Hora	Fonte	Título	Código	Companhia
04/07/2022	20:40	TipRanks	Goldman Sachs Sticks to Their Buy Rating for Omni Bridgeway (IMMFF)	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
15/03/2022	12:35	TipRanks	Omni Bridgeway (IMMFF) Receives a Buy from Goldman Sachs	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
17/01/2013	13:25	Edgar (US Regulatory)	Revocation of Exchange Act Registration Pursuant to Section 12(j) (revoked)	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
17/01/2013	03:00	OTC Markets	Revoked Security	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
22/12/2012	03:00	OTC Markets	Tier Change	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
20/12/2012	03:00	OTC Markets	Suspended Security	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
20/12/2012	03:00	OTC Markets	Caveat Emptor Status Change	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
10/08/2011	06:00	GlobeNewswire Inc.	Immune Network to Start Clinical Trial of Oral Mycobacterium Vaccae in Tuberculosis Patients	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
09/07/2011	07:57	GlobeNewswire Inc.	Immunitor Presents V5 Trial Data and Receives Award at TB Conference in Hong Kong	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
07/07/2011	11:33	GlobeNewswire Inc.	Herbal TB Immunotherapy to be Presented at Hong Kong Conference	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
30/05/2011	11:14	GlobeNewswire Inc.	TB Immunotherapy Collaboration Agreement With Stirling Products and Zodiac Capital	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
03/03/2011	12:07	GlobeNewswire Inc.	Ekomed Agrees to Collaboration on TB Immunotherapy	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
28/02/2011	08:22	GlobeNewswire Inc.	Immunitor Presents Positive TB Treatment Data at African Conference	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
14/02/2011	08:57	GlobeNewswire Inc.	Immunitor CEO Joins Immune Network Board of Directors	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
24/01/2011	07:43	GlobeNewswire Inc.	Immunitor Releases Positive Results of TB Immunotherapy From Its Second Clinical Site	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
17/01/2011	08:22	GlobeNewswire Inc.	Immunitor Deal Terms Approved by New Board of Directors	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
30/12/2010	07:41	GlobeNewswire Inc.	Immunitor Publishes Interim Data From Phase IIb imm01 TB Trial	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
13/12/2010	13:10	GlobeNewswire Inc.	Immunitor Completes Business Trip to China and Presents at Chinese Academy of Science Annual TB Meeting	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
29/11/2010	10:38	GlobeNewswire Inc.	Immunitor Awarded the Key U.S. Patent Related to Oral Vaccine Technology Platform	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
15/11/2010	02:21	GlobeNewswire Inc.	Immunitor Completes Phase IIb imm01 Trial Enrollment and Plans Further Trials of V5	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
01/11/2010	11:42	GlobeNewswire Inc.	Immunitor Phase 2b imm01 Trial Enrollment Scheduled to Complete Next Week	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
25/10/2010	09:29	GlobeNewswire Inc.	Immunitor Therapy is a Potential Breakthrough Against Tuberculosis	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
16/09/2010	10:58	GlobeNewswire Inc.	Immune Network Ltd. Announces Intent to Acquire Oral Vaccine Technology Platform	USOTC:IMMFF	Omni Bridgeway Ltd (PK)

Apresentando as notícias mais relevantes sobre:USOTC:IMMFF

1

Índice Bovespa

Sequoia Logistica e Tran... ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições